BG63460B1 - D-манитол и метод за неговото получаване - Google Patents

D-манитол и метод за неговото получаване Download PDF

Info

Publication number
BG63460B1
BG63460B1 BG102818A BG10281898A BG63460B1 BG 63460 B1 BG63460 B1 BG 63460B1 BG 102818 A BG102818 A BG 102818A BG 10281898 A BG10281898 A BG 10281898A BG 63460 B1 BG63460 B1 BG 63460B1
Authority
BG
Bulgaria
Prior art keywords
mannitol
crystals
examples
hydrochloride
tablet
Prior art date
Application number
BG102818A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG102818A (en
Inventor
Tomohiro Yoshinari
Fritz Schueckler
Norbert Poellinger
Shinji Maegata
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14109240&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG63460(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of BG102818A publication Critical patent/BG102818A/xx
Publication of BG63460B1 publication Critical patent/BG63460B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/18—Polyhydroxylic acyclic alcohols
    • C07C31/26—Hexahydroxylic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/74—Separation; Purification; Use of additives, e.g. for stabilisation
    • C07C29/76—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Steroid Compounds (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
BG102818A 1996-04-16 1998-10-07 D-манитол и метод за неговото получаване BG63460B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9440196 1996-04-16
PCT/JP1997/001286 WO1997038960A1 (en) 1996-04-16 1997-04-14 D-mannitol and its preparation

Publications (2)

Publication Number Publication Date
BG102818A BG102818A (en) 1999-05-31
BG63460B1 true BG63460B1 (bg) 2002-02-28

Family

ID=14109240

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102818A BG63460B1 (bg) 1996-04-16 1998-10-07 D-манитол и метод за неговото получаване

Country Status (27)

Country Link
US (1) US6503918B2 (zh)
EP (1) EP0902777B2 (zh)
KR (1) KR20000005486A (zh)
CN (1) CN1221398A (zh)
AT (1) ATE202768T1 (zh)
AU (1) AU718658B2 (zh)
BG (1) BG63460B1 (zh)
BR (1) BR9708672A (zh)
CA (1) CA2251092A1 (zh)
CU (1) CU22776A3 (zh)
CZ (1) CZ333698A3 (zh)
DE (1) DE69705516T3 (zh)
DK (1) DK0902777T4 (zh)
EA (1) EA000968B1 (zh)
ES (1) ES2158540T5 (zh)
GR (1) GR3036760T3 (zh)
HU (1) HUP9902165A3 (zh)
ID (1) ID16566A (zh)
IL (1) IL126580A (zh)
NO (2) NO311349B1 (zh)
NZ (1) NZ332313A (zh)
PL (1) PL329614A1 (zh)
PT (1) PT902777E (zh)
SK (1) SK282768B6 (zh)
TR (1) TR199802079T2 (zh)
TW (1) TW515787B (zh)
WO (1) WO1997038960A1 (zh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10008506A1 (de) * 2000-02-24 2001-09-13 Bayer Ag Verfahren zur Herstellung von pharmazeutischen Darreichungsformen
FR2807034B1 (fr) † 2000-03-29 2002-06-14 Roquette Freres Mannitol pulverulent et son procede de fabrication
US20040022848A1 (en) * 2000-09-19 2004-02-05 Hiroshi Kikuchi Medicinal composition
US6855333B1 (en) 2000-10-03 2005-02-15 Mutual Pharmaceutical Co., Inc. Stabilization of solid thyroid drug formulations
US6979462B1 (en) 2000-10-03 2005-12-27 Mutual Pharmaceutical Co., Inc. Stabilization of solid drug formulations
DE10161402A1 (de) * 2001-12-13 2003-06-18 Merck Patent Gmbh Verfahren zur Herstellung von direkt tablettierbarem beta-Mannit
ES2752452T3 (es) * 2002-05-14 2020-04-06 Dupont Nutrition Usa Inc Composiciones de hidrocoloides de celulosa microcristalinas codesgastadas por atrición y método para su fabricación
US8163797B2 (en) * 2003-12-31 2012-04-24 Actavis Elizabeth Llc Method of treating with stable pravastatin formulation
US7879382B2 (en) * 2005-09-30 2011-02-01 Fmc Corporation Stabilizers and compositions and products comprising same
CA2634232C (en) * 2005-12-28 2013-08-20 Takeda Pharmaceutical Company Limited Method of producing solid preparation disintegrating in the oral cavity
CA2642952C (en) 2006-02-20 2014-09-02 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition comprising oseltamivir phosphate
US7998505B2 (en) * 2006-10-27 2011-08-16 Fmc Corporation Dry granulation binders, products, and use thereof
EP2133096A4 (en) 2007-03-13 2011-11-16 Dainippon Sumitomo Pharma Co IN THE MOUTHING TABLET
US8389778B2 (en) * 2007-05-22 2013-03-05 Aptuit (West Lafayette), Llc Preparation of mannitol modification III
DE102007052070A1 (de) 2007-10-30 2009-05-07 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Candesartancilexetil
EP3093011B1 (de) 2010-12-17 2021-03-24 Merck Patent GmbH Verfahren zur herstellung von direkt tablettierbarem delta-mannit
US9055757B2 (en) 2011-10-05 2015-06-16 Fmc Corporation Stabilizer composition of co-attrited microcrystalline cellulose and carboxymethylcellulose, method for making, and uses
WO2013052114A1 (en) 2011-10-05 2013-04-11 Fmc Corporation Stabilizer composition of microcrystalline cellulose and carboxymethylcellulose, method for making, and uses
CN103987273B (zh) 2011-12-09 2018-07-27 Fmc有限公司 具有优良胶强度的共磨碎的稳定剂组合物
WO2016012854A1 (en) * 2014-07-21 2016-01-28 Roquette Freres Sugar compositions for tableting by direct compression
IT201900002857A1 (it) 2019-02-27 2020-08-27 Ntc S R L Procedimento di riempimento di contenitori con una polvere
CN113116843A (zh) * 2021-05-11 2021-07-16 福建海西新药创制有限公司 一种含有缬沙坦的药物组合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145146A (en) 1961-10-31 1964-08-18 Warner Lambert Pharmaceutical Modified mannitol for pharmaceutical tablets
DE3245170A1 (de) 1982-12-07 1984-06-07 Merck Patent Gmbh, 6100 Darmstadt Verbesserter sorbit, verfahren zur herstellung und verwendung
FR2571046B1 (fr) 1984-10-03 1987-10-16 Roquette Freres Procede de preparation de mannitol granulaire directement compressible
FR2571045B1 (fr) 1984-10-03 1987-12-11 Roquette Freres Mannitol granulaire directement compressible et son procede de fabrication
JPH0653658B2 (ja) 1984-12-17 1994-07-20 中外製薬株式会社 安定な錠剤の製造法
NO177005C (no) 1988-01-20 1995-07-05 Bayer Ag Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen
ATE128959T1 (de) 1989-01-24 1995-10-15 Spi Polyols Inc Kryoschützende kristalline sorbitolkügelchen.
ATE99545T1 (de) 1989-03-29 1994-01-15 Takeda Chemical Industries Ltd Zusammensetzung mit einer verbindung der vitamin b-gruppe und ihre herstellung.
US5177080A (en) 1990-12-14 1993-01-05 Bayer Aktiengesellschaft Substituted pyridyl-dihydroxy-heptenoic acid and its salts
HU217629B (hu) * 1991-12-12 2000-03-28 Novartis Ag. Eljárás fluvasztatint tartalmazó stabilizált gyógyszerkészítmények előállítására
FR2710637B1 (fr) † 1993-09-28 1995-12-08 Roquette Freres Mannitol pulvérulent de friabilité modérée et son procédé de préparation.
AUPM411494A0 (en) 1994-02-25 1994-03-24 Central Sydney Area Health Service Method and device for the provocation of upper or lower airway narrowing and/or the induction of sputum
US6235947B1 (en) * 1997-04-14 2001-05-22 Takeda Chemical Industries, Ltd. D-mannitol and its preparation

Also Published As

Publication number Publication date
EP0902777B2 (en) 2004-06-16
NO984803L (no) 1998-12-16
ES2158540T3 (es) 2001-09-01
GR3036760T3 (en) 2001-12-31
ID16566A (id) 1997-10-16
AU718658B2 (en) 2000-04-20
CA2251092A1 (en) 1997-10-23
DK0902777T3 (da) 2001-09-24
DE69705516T2 (de) 2002-04-25
BG102818A (en) 1999-05-31
DE69705516D1 (de) 2001-08-09
SK282768B6 (sk) 2002-12-03
US6503918B2 (en) 2003-01-07
NO311349B1 (no) 2001-11-19
EP0902777B1 (en) 2001-07-04
NO20012249D0 (no) 2001-05-07
HUP9902165A2 (hu) 1999-11-29
TW515787B (en) 2003-01-01
AU2522297A (en) 1997-11-07
NO984803D0 (no) 1998-10-15
IL126580A0 (en) 1999-08-17
EA000968B1 (ru) 2000-08-28
WO1997038960A1 (en) 1997-10-23
US20020107420A1 (en) 2002-08-08
CN1221398A (zh) 1999-06-30
BR9708672A (pt) 1999-08-03
EP0902777A1 (en) 1999-03-24
PL329614A1 (en) 1999-03-29
ES2158540T5 (es) 2004-11-16
SK143298A3 (en) 1999-04-13
PT902777E (pt) 2001-11-30
CU22776A3 (es) 2002-07-24
DE69705516T3 (de) 2004-09-30
NZ332313A (en) 2000-02-28
IL126580A (en) 2001-08-08
NO20012249L (no) 1998-12-16
EA199800888A1 (ru) 1999-04-29
HUP9902165A3 (en) 2001-01-29
ATE202768T1 (de) 2001-07-15
CZ333698A3 (cs) 1999-01-13
DK0902777T4 (da) 2004-10-11
KR20000005486A (ko) 2000-01-25
TR199802079T2 (xx) 1999-02-22

Similar Documents

Publication Publication Date Title
BG63460B1 (bg) D-манитол и метод за неговото получаване
US6235947B1 (en) D-mannitol and its preparation
EP0580428B1 (en) Microparticle preparation and production thereof
EP0535937B2 (en) Prolonged release microparticle preparation and production of the same
US6113941A (en) Substained release microcapsule of physiologically active compound which is slightly water soluble at pH 6 to 8
EP1940359B1 (de) Verfahren zur herstellung von direkttablettierbaren ibuprofen-formulierungen
JP3126683B2 (ja) Ｄ−マンニトールおよびその製造法
EP2814465B1 (en) Pharmaceutical formulation having improved stability
US20010001106A1 (en) D-mannitol and its preparation
US7018653B2 (en) Method for preparing solid dosage form of desmopressin
CN102247367B (zh) 一种含替米沙坦氨氯地平药物组合物及制备方法
CN1805741A (zh) 利用湿法造粒制备的稳定的阿托伐他汀组合物
Singh et al. Liquisolid compacts of glimepiride: an approach to enhance the dissolution of poorly water soluble drugs
DE60303872T2 (de) Verfahren zur Herstellung einer festen oralen Dosierungsform von Desmopressin
JP2001114712A (ja) Ｄ−マンニトールおよびその製造法
JPH1135487A (ja) 錠剤用組成物及び打錠方法
JP3232687B2 (ja) イミダプリル含有製剤
US20120100211A1 (en) Material and process for incorporation of low dosage active pharmaceutical ingredients and use thereof
EP2808012A1 (en) Method for producing dosage form comprising odanacatib
EP2621472A1 (en) Dry processing of atazanavir